Nanoanalysis involves the application of advanced techniques and methodologies at the nanoscale to scrutinize and understand the characteristics of pharmaceutical materials. This emerging field plays a pivotal role in drug development, quality control, and ensuring the efficacy of pharmaceutical products. Techniques such as scanning electron microscopy (SEM), transmission electron microscopy (TEM), atomic force microscopy (AFM), and X-ray photoelectron spectroscopy (XPS) are employed to investigate the nanoscale properties of drug formulations, nanoparticles, and biomaterials.
Nanoanalysis facilitates a detailed examination of particle size, morphology, surface topography, and elemental composition, enabling researchers to optimize drug delivery systems, enhance bioavailability, and address challenges associated with solubility and stability. The insights gained through nanoanalysis contribute to the design of more efficient and targeted drug delivery systems, ultimately advancing the development of safer and more effective pharmaceuticals. As the pharmaceutical industry continues to embrace nanotechnology, nanoanalysis becomes an indispensable tool for researchers and scientists striving to unlock the full potential of nanomaterials in drug development.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico